Shareholder information

2020欧洲杯体育在线平台This data might not be the latest available

Annual General Meeting

AstraZeneca’s 2020 Annual General Meeting (AGM) took place on 29 April 2020. To help ensure the safety and security of our workforce and shareholders during the COVID-19 pandemic, the AGM took place behind closed doors in compliance with the ‘Stay at Home Measures’ passed into law in England and Wales on 26 March 2020. Shareholders were encouraged to vote on the AGM resolutions by appointing the Chairman of the AGM as their proxy.

Shareholder forms

2020欧洲杯体育在线平台You can download a selection of our registrar instruction forms here. If you can't find the form you require please go to the


Completed forms should be returned to:

Aspect House
Spencer Road
West Sussex
BN99 6DA

For more information, shareholder services and changes to personal details, visit the Equiniti website.

Investor enquiries

Main Contacts

Thomas Kudsk Larsen

2020欧洲杯体育在线平台Henry Wheeler


Josie Afolabi

BioPharmaceuticals (Respiratory & Immunology)

Craig Marks

2020欧洲杯体育在线平台Finance, fixed income

Christer Gruvris

BioPharmaceuticals (CV, Metabolism)

2020欧洲杯体育在线平台Tom Waldron

2020欧洲杯体育在线平台Other medicines

2020欧洲杯体育在线平台Jennifer Kretzmann

Corporate access, retail investors

Nick Stone

BioPharmaceuticals (Renal), ESG

2020欧洲杯体育在线平台US general enquiries